Related Experiment Video

Updated: Jul 14, 2026

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on: October 17, 2025

Imatinib mesylate therapy in chronic myeloid leukaemia: the floodgates opened

M B Agarwal

    The Journal of the Association of Physicians of India
    |June 19, 2007
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Related Experiment Videos

    Last Updated: Jul 14, 2026

    Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
    04:36

    Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

    Published on: October 17, 2025

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
    07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

    Articles linked to this work by shared authors, journal, and citation graph.

    Multiple Myeloma: Treatment is Getting Individualized.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2016

    Safety and efficacy of indigenous equine antithymocyte globulin along with cyclosporine in subjects with acquired aplastic anemia.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2015

    Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia.

    Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology·2015

    Report of chronic myeloid leukemia in chronic phase from Ashirwad Hematology Centre, Mumbai, 2002-2009.

    Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology·2014

    Balancing efficacy and bleeding risk in the prevention of stroke due to atrial fibrillation with newer oral anticoagulants.

    Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2013

    Deferasirox: oral, once daily iron chelator--an expert opinion.

    Indian journal of pediatrics·2010

    A Conversation with ChatGPT about Pleural Effusion.

    The Journal of the Association of Physicians of India·2026

    Assessing the Impact of the District Residency Program on Pre- and Paraclinical Postgraduate Training in India.

    The Journal of the Association of Physicians of India·2026

    Imeglimin in Type 2 Diabetes Mellitus: Expert Opinions and Consensus in Indian Context.

    The Journal of the Association of Physicians of India·2026

    Idiopathic Intracranial Hypertension Masquerading as Cerebral Venous Sinus Thrombosis: A Diagnostic Challenge.

    The Journal of the Association of Physicians of India·2026

    When Febrile Seizures Are Not Benign: An Unusual Cause of Dyke-Davidoff-Masson Syndrome.

    The Journal of the Association of Physicians of India·2026

    Expanding the Spectrum: Isolated Acute Diencephalitis as the Initial Manifestation of Neuromyelitis Optica Spectrum Disorder.

    The Journal of the Association of Physicians of India·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us